Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to 0.77%.

  • Fortress Biotech's Return on Capital Employed rose 8400.0% to 0.77% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.77%, marking a year-over-year increase of 8400.0%. This contributed to the annual value of 1.31% for FY2024, which is 3300.0% down from last year.
  • According to the latest figures from Q3 2025, Fortress Biotech's Return on Capital Employed is 0.77%, which was up 8400.0% from 0.94% recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Return on Capital Employed peaked at 0.33% during Q1 2021, and registered a low of 2.6% during Q3 2023.
  • For the 5-year period, Fortress Biotech's Return on Capital Employed averaged around 1.18%, with its median value being 1.1% (2025).
  • Per our database at Business Quant, Fortress Biotech's Return on Capital Employed plummeted by -17100bps in 2023 and then skyrocketed by 10600bps in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Return on Capital Employed stood at 0.61% in 2021, then plummeted by -83bps to 1.12% in 2022, then plummeted by -71bps to 1.92% in 2023, then increased by 11bps to 1.72% in 2024, then soared by 55bps to 0.77% in 2025.
  • Its last three reported values are 0.77% in Q3 2025, 0.94% for Q2 2025, and 1.1% during Q1 2025.